• ÈÈÏߵ绰
    ²úÆ·ÐÂÎÅ

    8019¸ÄÐÔmdiÔÚÒ½Ó÷óÁÏÖеÄÉúÎïÏàÈÝÐÔÓ¦ÓÃDZÁ¦

    8019¸ÄÐÔmdiÔÚÒ½Ó÷óÁÏÖеÄÉúÎïÏàÈÝÐÔÓ¦ÓÃDZÁ¦

    ÒýÑÔ£º´Ó¡°½ºË®¡±µ½¡°Æ¤·ô¡±£¬²ÄÁϵĽø»¯Ö®Â·

    Èç¹ûÒªÎÊÏÖ´úҽѧÖУ¬²»ÆðÑÛÈ´²»¿É»òȱµÄ²ÄÁÏÊÇʲô£¿´ð°¸¿ÉÄܲ»ÊÇÊÖÊõµ¶¡¢²»ÊÇ·ìºÏÏߣ¬¶øÊÇÒ»ÖÖÎÒÃÇÆ½Ê±²»Ì«»á×¢ÒâµÄ¶«Î÷¡ª¡ªÒ½Ó÷óÁÏ¡£ËüÌùÔÚÉË¿ÚÉÏ£¬Ä¬Ä¬ÊØ»¤×ÅÎÒÃǵÄÉíÌ壬·ÀÖ¹¸ÐȾ¡¢´Ù½øÓúºÏ¡£¶øÔÚÕâ±³ºó£¬ÓÐÒ»ÖÖÉñÃØµÄ²ÄÁÏÕýÇÄÈ»µÇ³¡£¬Ëü¾ÍÊÇ¡ª¡ª8019¸ÄÐÔmdi¡£

    ±ð¿´Ãû×ÖÞÖ¿Ú£¬ÆäʵËüµÄÀ´Í·²»Ð¡¡£mdi£¬È«³ÆÊǶþ±½»ù¼×Íé¶þÒìÇèËáõ¥£¨methylene diphenyl diisocyanate£©£¬ÊǾ۰±õ¥²ÄÁϵÄÖØÒªÔ­ÁÏÖ®Ò»¡£¾­¹ýÌØ¶¨¹¤ÒÕ¸ÄÐÔºóµÄ8019 mdi£¬ÔÚ±£³ÖÔ­ÓÐÓÅÒìÐÔÄܵÄͬʱ£¬¾ß±¸Á˸üÇ¿µÄÉúÎïÏàÈÝÐԺ͸üκ͵ÄʹÓÃÌåÑ飬ÓÈÆäÊÊÓÃÓÚ¶Ô°²È«ÐÔÒªÇ󼫸ߵÄÒ½ÁÆÁìÓò¡£

    ÕâÆªÎÄÕ£¬ÔÛÃǾÍÀ´ÁÄÁÄÕâ8019¸ÄÐÔmdiµ½µ×ÊǸöʲô½ÇÉ«£¬ËüΪʲôÄÜÔÚÒ½Ó÷óÁÏÖдó·ÅÒì²Ê£¬ÒÔ¼°Î´À´»¹ÓÐÄÄЩֵµÃÆÚ´ýµÄ·¢Õ¹·½Ïò¡£µ±È»£¬ÎªÁËÈÃÄã¶ÁµÃÇáËÉÓä¿ì£¬ÔÛÒ²¾¡Á¿²»ËµÄÇЩÈÃÈË´ò¹þÇ·µÄרҵÊõÓ¶à½²µãʵÔڵġ¢½ÓµØÆøµÄÄÚÈÝ¡£


    Ò»¡¢Ê²Ã´ÊÇ8019¸ÄÐÔmdi£¿

    1.1 ԭʼmdiµÄ»ù±¾ÌØÐÔ

    mdiÔ­±¾ÊÇÒ»Öֹ㷺ÓÃÓÚ¹¤ÒµÁìÓòµÄ»¯Ñ§ÎïÖÊ£¬±ÈÈçÖÆÔìÅÝÄ­ËÜÁÏ¡¢½ºð¤¼Á¡¢Í¿ÁϵȵÈ¡£ËüµÄÖ÷ÒªÌØµã°üÀ¨£º

    • ¸ß·´Ó¦»îÐÔ
    • ÄÍÈÈ¡¢ÄÍÀÏ»¯
    • ³ÉĤÐÔÄܺÃ
    • ¿ÉÓëÆäËû¾ÛºÏÎï¹²»ìÐγɸ´ºÏ²ÄÁÏ

    µ«Ô­Ê¼mdiÖ±½ÓÓÃÓÚÈËÌå½Ó´¥²úƷʱ´æÔÚÒ»¶¨µÄ´Ì¼¤ÐԺͶ¾ÐÔ·çÏÕ£¬ÓÈÆäÊÇÔÚδÍêÈ«¹Ì»¯µÄÇé¿öÏ£¬¿ÉÄÜ»áÊͷųöÓÎÀëmdiµ¥Ì壬Òý·¢¹ýÃô»òÑ×Ö¢·´Ó¦¡£

    1.2 ¸ÄÐÔµÄÒâÒåÓë¼¼ÊõÊÖ¶Î

    ΪÁ˽â¾öÕâ¸öÎÊÌ⣬¿ÆÑÐÈËÔ±¶Ômdi½øÐÐÁË¡°ÕûÈÝʽ¡±µÄ¸ÄÔ죬Ҳ¾ÍÊÇËùνµÄ¸ÄÐÔ´¦Àí¡£Í¨¹ýÒýÈëÌØ¶¨µÄ¹ÙÄÜÍÅ»òÕßÓëÆäËû»¯ºÏÎï½øÐÐÔ¤¾Û·´Ó¦£¬Ê¹mdi±äµÃ¸ü¼ÓκÍ¡¢Îȶ¨£¬²¢ÇÒ¸üÊʺÏÓÃÓÚÒ½ÁÆÓÃ;¡£

    ³£¼ûµÄ¸ÄÐÔ·½Ê½°üÀ¨£º

    ¸ÄÐÔ·½·¨ ÌØµã Ó¦ÓÃÓÅÊÆ
    ·â¶Ë¸ÄÐÔ ¼õÉÙÓÎÀëµ¥ÌåÊÍ·Å Ìá¸ß°²È«ÐÔ
    ôÇ»ù»¯´¦Àí Ôö¼ÓÇ×Ë®ÐÔ ¸üÊʺÏÓëÉúÎï×éÖ¯½Ó´¥
    Ô¤¾ÛÌåºÏ³É ¿ØÖƽ»ÁªÃÜ¶È ÌáÉý²ÄÁÏÈáÈÍÐԺ͵¯ÐÔ

    ¶ø8019¸ÄÐÔmdi£¬ÕýÊÇÆäÖÐÒ»ÖÖ¾ßÓдú±íÐԵIJúÎï¡£Ëü²»½ö±£ÁôÁËmdiÔ­ÓеĻúеǿ¶ÈºÍÕ³½ÓÐÔÄÜ£¬»¹´ó´ó½µµÍÁËÆä¶ÔÈËÌåµÄDZÔÚΣº¦¡£


    ¶þ¡¢Ò½Ó÷óÁϵÄÐèÇóÓëÌôÕ½

    2.1 Ò½Ó÷óÁϵĻù±¾¹¦ÄÜÐèÇó

    Ò½Ó÷óÁϲ»ÊÇÒ»¿é¼òµ¥µÄ²¼£¬ËüÐèÒªÂú×ãһϵÁÐÑÏ¿ÁµÄ¹¦ÄÜÐèÇó£¬Ö÷Òª°üÀ¨£º

    • ±£»¤´´Ã棺·ÀÖ¹Íâ½çÎÛȾºÍϸ¾úÇÖÈë
    • ÎüÊÕÉøÒº£ºÓÐЧ¹ÜÀíÉ˿ڷÖÃÚÎï
    • ´Ù½øÓúºÏ£ºÎ¬³ÖʪÈó»·¾³£¬ÓÐÀûÓÚϸ°ûÔÙÉú
    • ÉúÎïÏàÈÝÐԺ㺲»ÒýÆð¹ýÃô¡¢Ñ×Ö¢µÈ²»Á¼·´Ó¦
    • Í¸ÆøÊæÊÊ£º±ÜÃâÃÆÈȸУ¬Ìá¸ß»¼ÕßÒÀ´ÓÐÔ

    2.2 ´«Í³·óÁϲÄÁϵľÖÏÞÐÔ

    ĿǰÊÐÃæÉϳ£ÓõÄÒ½Ó÷óÁϲÄÁϰüÀ¨É´²¼¡¢ÔåËáÑΡ¢Ë®Äý½º¡¢ÅÝÄ­·óÁϵÈ¡£ËäÈ»¸÷ÓÐǧÇµ«Ò²´æÔÚ²»ÉÙÎÊÌ⣺

    ²ÄÁÏÀàÐÍ Óŵã ȱµã
    É´²¼ ³É±¾µÍ¡¢Ò×»ñÈ¡ ÎüÊÕÐԲÈÝÒ×Õ³Á¬ÉË¿Ú
    ÔåËáÑÎ ÎüʪÐÔÇ¿¡¢Ö¹ÑªÐ§¹ûºÃ ÈáÈÍÐԲ¼Û¸ñÆ«¸ß
    Ë®Äý½º ±£ÊªÐ§¹ûºÃ ÒׯÆËð¡¢²»ÊÊÓÃÓÚ´óÁ¿ÉøÒº
    ÅÝÄ­·óÁÏ ÈáÈí¡¢ÎüË®ÐÔÇ¿ ³É±¾¸ß¡¢²¿·ÖÆ·ÅÆ´æÔÚÖÂÃô·çÏÕ

    ÕâЩ²ÄÁÏÔÚʵ¼ÊÓ¦ÓÃÖÐÍùÍùÃæÁÙÒ»¸öºËÐÄì¶Ü£º¼ÈÒª×㹻ǿ´ó£¬ÓÖÒª×ã¹»ÎÂÈá¡£Õâ¾Í¶ÔÐÂÐͲÄÁÏÌá³öÁ˸ü¸ßµÄÒªÇó¡£


    Èý¡¢8019¸ÄÐÔmdiΪºÎÊʺÏ×öÒ½Ó÷óÁÏ£¿

    3.1 °²È«ÐÔ£º²»ÔÙ¡°À±ÑÛ¾¦¡±

    Ç°ÃæËµ¹ý£¬Ô­Ê¼mdi´æÔÚÒ»¶¨µÄ¶¾ÐÔ·çÏÕ¡£¶ø8019¸ÄÐÔmdiͨ¹ý·â¶Ë¼¼ÊõºÍ·Ö×ӽṹÓÅ»¯£¬ÏÔÖø½µµÍÁËÓÎÀëmdiµÄº¬Á¿£¬Ê¹ÆäÔÚÉúÎï»·¾³Öиü¼ÓÎȶ¨¡£

    ÒÔÏÂÊÇijʵÑéÊҶԱȲâÊÔÊý¾Ý£º

    Ö¸±ê ԭʼmdi 8019¸ÄÐÔmdi
    ÓÎÀëmdiº¬Á¿£¨ppm£© >500 <20
    ϸ°û¶¾ÐԵȼ¶£¨iso 10993£© ÖжÈÖÁÖØ¶È ÎÞ¶¾¼¶
    ÖÂÃôÂÊ£¨¶¯ÎïÄ£ÐÍ£© 15%~20% <2%

    ¿ÉÒÔ¿´µ½£¬8019¸ÄÐÔmdiÔÚÉúÎﰲȫÐÔ·½Ãæ±íÏÖÍ»³ö£¬ÍêÈ«¿ÉÒÔʤÈÎÒ½Ó÷óÁÏÕâÖÖ¡°ÌùÉí·þÎñ¡±µÄ¹¤×÷¡£

    3.2 ÐÔÄÜÓÅÊÆ£º¸ÕÈá²¢¼Ã

    ³ýÁ˰²È«£¬»¹µÃÄÜ´ò¡£8019¸ÄÐÔmdiÔÚÐÔÄÜ·½ÃæÒ²Óв»ÉÙÁÁµã£º

    £¨1£©Á¼ºÃµÄÕ³¸½ÐÔÓë°þÀëÁ¦¿ØÖÆ

    Ëü¿ÉÒÔÉè¼Æ³É²»Í¬Õ³ÐԳ̶ȵIJúÆ·£¬¼ÈÄÜÀι̵ØÌùºÏÔÚÆ¤·ôÉÏ£¬ÓÖ²»»áÔÚ½Ò³ýʱÔì³É¶þ´ÎÉ˺¦¡£

    ²ÎÊý ÊýÖµ·¶Î§
    ³õʼճ×ÅÁ¦£¨n/25mm£© 0.8~2.5
    °þÀëÇ¿¶È£¨n/25mm£© 0.3~1.2
    ³Öճʱ¼ä£¨h£© ¡Ý72

    £¨2£©ÓÅÒìµÄÎüË®Ó뱣ˮÄÜÁ¦

    ͨ¹ýµ÷½ÚÅä·½£¬¿ÉÒÔ¿ØÖƲÄÁϵÄÇ×Ë®/Êèˮƽºâ£¬´Ó¶øÊµÏÖ¶ÔÉøÒºµÄÁ¼ºÃ¹ÜÀí¡£

    ÎüË®ÂÊ£¨g/g£© ±£³ÖÂÊ£¨24h£©
    8~15 85%ÒÔÉÏ

    £¨3£©Á¼ºÃµÄÁ¦Ñ§ÐÔÄÜ

    ÎÞÂÛÊÇÀ­ÉìÇ¿¶È»¹Êǻص¯ÐÔ£¬¶¼ÄÜÂú×ã·óÁÏÔÚ¸´ÔÓ²¿Î»£¨Èç¹Ø½Ú£©Ê¹ÓõÄÐèÒª¡£

    ¿¹À­Ç¿¶È£¨mpa£© ¶ÏÁÑÉ쳤ÂÊ£¨%£©
    5~8 200~400

    ËÄ¡¢Ó¦Óó¡¾°·ÖÎö£º´ÓÈÕ³£»¤Àíµ½¸ß¶ËÒ½ÁÆ

    4.1 ´´ÉË·óÁÏ

    ¶ÔÓÚÍâÉË¡¢²ÁÉË¡¢Ð¡ÊÖÊõÇпڵȣ¬8019¸ÄÐÔmdiÖÆ³ÉµÄ·óÁÏ¿ÉÒÔÌṩÁ¼ºÃµÄ±£»¤ºÍÊæÊÊÌåÑ飬ÓÈÆäÊʺ϶ùͯºÍÃô¸ÐÈËȺ¡£

    ¿¹À­Ç¿¶È£¨mpa£© ¶ÏÁÑÉ쳤ÂÊ£¨%£©
    5~8 200~400

    ËÄ¡¢Ó¦Óó¡¾°·ÖÎö£º´ÓÈÕ³£»¤Àíµ½¸ß¶ËÒ½ÁÆ

    4.1 ´´ÉË·óÁÏ

    ¶ÔÓÚÍâÉË¡¢²ÁÉË¡¢Ð¡ÊÖÊõÇпڵȣ¬8019¸ÄÐÔmdiÖÆ³ÉµÄ·óÁÏ¿ÉÒÔÌṩÁ¼ºÃµÄ±£»¤ºÍÊæÊÊÌåÑ飬ÓÈÆäÊʺ϶ùͯºÍÃô¸ÐÈËȺ¡£

    4.2 ÂýÐÔÉ˿ڻ¤Àí

    ÌÇÄò²¡×ãÀ£Ññ¡¢Ñ¹´¯µÈÂýÐÔÉË¿ÚÐèÒª³¤ÆÚ¹ÜÀí£¬ÕâÀà·óÁϲ»½öÄÜÎüÊÕÉøÒº£¬»¹ÄÜά³ÖʪÈó»·¾³£¬´Ù½øÈâÑ¿Éú³¤¡£

    4.3 Êõºó·óÁÏ

    ÊÖÊõºóÉ˿ڶԷóÁϵÄÒªÇ󼫸ߣ¬²»½öÒª·ÀË®·À¾ú£¬»¹Òª¼õÉٰ̺ÛÐγÉ¡£8019¸ÄÐÔmdiÔÚÕâ·½Ãæ±íÏÖ³öÉ«£¬ÒÑÔÚ¶à¼ÒÒ½ÔºÊÔÓ÷´À¡Á¼ºÃ¡£

    4.4 ÌØÊⲿλӦÓÃ

    ÀýÈç¶úºó¡¢±ÇÒí¡¢ÊÖÖ¸¹Ø½ÚµÈ²¿Î»£¬´«Í³·óÁÏÈÝÒ×ÍÑÂä»ò²»ÊÊ£¬¶ø8019¸ÄÐÔmdi²ÄÁÏÒòÆäÁ¼ºÃµÄÑÓÕ¹ÐÔºÍÊÊÐÎÐÔ£¬³ÉΪÀíÏëÑ¡Ôñ¡£


    Îå¡¢¹úÄÚÍâÑо¿ÏÖ×´Óë·¢Õ¹Ç÷ÊÆ

    5.1 ¹úÄÚÑо¿½øÕ¹

    ½üÄêÀ´£¬Ëæ×Źú¼Ò¶ÔÉúÎïÒ½Ò©²ÄÁϵÄÖØÊÓ£¬Ô½À´Ô½¶àµÄ¸ßУºÍÆóÒµ¿ªÊ¼¹Ø×¢8019¸ÄÐÔmdiÔÚÒ½ÁÆÁìÓòµÄÓ¦Óá£

    ÒÔÏÂÊÇһЩ´ú±íÐԳɹû£º

    µ¥Î» Ñо¿ÄÚÈÝ ³É¹û
    Õã½­´óѧ ÉúÎïÏàÈÝÐÔÆÀ¹À isoÈÏ֤ͨ¹ý
    ÖпÆÔºÉϺ£ÓлúËù ·Ö×ӽṹÓÅ»¯ ÐÂÐÍÔ¤¾ÛÌåÖÆ±¸³É¹¦
    ÉîÛÚijҽÁÆÆ÷е¹«Ë¾ ·óÁϲúÆ·¿ª·¢ ½øÈëÁÙ´²ÊÔÑé½×¶Î

    5.2 ¹ú¼ÊÇ°ÑØ¶¯Ì¬

    Å·ÃÀ¹ú¼ÒÔÚ¾Û°±õ¥Ò½ÓòÄÁÏ·½ÃæÆð²½½ÏÔ磬ÒÑÓжà¸ö»ùÓÚ¸ÄÐÔmdiµÄÉÌÒµ»¯²úÆ·ÎÊÊÀ¡£

    ÀýÈ磺

    ¹«Ë¾ ²úÆ·Ãû³Æ ÌØµã
    3m health care tegaderm? plus ʹÓøÄÐÔ¾Û°±õ¥£¬Í¸ÆøÐÔÇ¿
    smith & nephew allevyn life ½áºÏÅÝÄ­Óë¹è½º²ã£¬Êʺϸ´ÔÓÉË¿Ú
    m?lnlycke health care biatain silicone ʹÓÃmdi»ùµ×£¬ÈáÈí²»´Ì¼¤

    ÕâЩ²úÆ·µÄ¹²Í¬µãÊǶ¼²ÉÓÃÁ˵ÍÖÂÃô¡¢¸ßÉúÎïÏàÈÝÐԵľ۰±õ¥Ìåϵ£¬¶ø8019¸ÄÐÔmdiÕýºÃ·ûºÏÕâÒ»Ç÷ÊÆ¡£


    Áù¡¢ÃæÁÙµÄÌôÕ½ÓëδÀ´Õ¹Íû

    6.1 ±ê×¼»¯Óë¼à¹ÜÎÊÌâ

    ¾¡¹Ü8019¸ÄÐÔmdiÔÚʵÑéÖбíÏÖÓÅÒ죬µ«ÔÚÕýʽÉÏÊÐǰÈÔÐèͨ¹ýÑϸñµÄÁÙ´²ÑéÖ¤ºÍ×¢²áÉóÅúÁ÷³Ì¡£Ä¿Ç°ÎÒ¹úÔÚ¸ÃÀà²ÄÁϵıê×¼ÖÆ¶¨ÉÏÉд¦ÓÚ̽Ë÷½×¶Î£¬Ø½Ð轨Á¢Í³Ò»µÄÆÀ¼ÛÌåϵ¡£

    6.2 ³É±¾ÓëÁ¿²úÆ¿¾±

    вÄÁϵÄÑз¢³É±¾½Ï¸ß£¬ÓÈÆäÊÇÔÚ³õÆÚÊÔ²ú½×¶Î£¬µ¥Î»³É±¾Ô¶¸ßÓÚ´«Í³²ÄÁÏ¡£ÈçºÎ½µµÍÉú²ú³É±¾¡¢ÊµÏÖ¹æÄ£»¯Éú²ú£¬ÊÇÏÂÒ»²½±ØÐë½â¾öµÄÎÊÌâ¡£

    6.3 ¶à¹¦Äܼ¯³ÉÇ÷ÊÆ

    δÀ´µÄÒ½Ó÷óÁϲ»Ö»ÊÇ¡°ÌùÉÏÈ¥¡±£¬¶øÊÇÒª¾ß±¸¸ü¶àÖÇÄܹ¦ÄÜ£¬ÀýÈ磺

    • ¿¹¾úÍ¿²ã
    • phÏìÓ¦
    • Ò©ÎﻺÊÍ
    • ÉË¿Ú״̬¼à²â£¨ÈçÑÕÉ«±ä»¯£©

    ¶ø8019¸ÄÐÔmdi×÷ΪһÖÖ»ù´¡Æ½Ì¨²ÄÁÏ£¬¾ß±¸Á¼ºÃµÄ¿ÉÐÞÊÎÐԺͼæÈÝÐÔ£¬·Ç³£ÊʺϽøÐж๦ÄÜÍØÕ¹¡£


    Æß¡¢½áÓһƬССµÄ·óÁÏ£¬³ÐÔØµÄÊÇÈËÀà¶Ô½¡¿µµÄÖ´×Å×·Çó

    ˵µ½µ×£¬8019¸ÄÐÔmdi²»¹ýÊÇÒ»¸ö»¯Ñ§Ãû´Ê£¬µ«Ëü±³ºóµÄ¹ÊÊ£¬È´¹Øºõÿһ¸öÊÜÉ˵ÄÈËÄÜ·ñ¸ü¿ì¿µ¸´£¬¹Øºõÿһ¸öÒ½»¤ÈËÔ±ÊÇ·ñÄÜÓÃÉϸü°²È«¸ßЧµÄ¹¤¾ß¡£

    ´Ó³õµÄ¹¤ÒµÔ­ÁÏ£¬µ½Èç½ñÓÐÍû×ß½øÇ§¼ÒÍò»§µÄÒ½Ó÷óÁÏ£¬8019¸ÄÐÔmdi×ß¹ýµÄÿһ²½£¬¶¼ÊǿƼ¼½ø²½ÓëÈËÎĹػ³½áºÏµÄËõÓ°¡£

    Ò²ÐíÓÐÒ»Ì죬µ±ÄãÇáÇá½Ò¿ªÒ»Æ¬·óÁÏʱ£¬²»»áÔÙ¾õµÃËüÖ»ÊÇÒ»¿éÆÕͨµÄ½º²¼£¬¶ø»áÏëÆðËü±³ºóµÄ¿ÆÑ§¡¢Î¶ÈÓëÏ£Íû¡£


    ²Î¿¼ÎÄÏ×

    ÒÔÏÂΪ±¾ÎÄÒýÓõIJ¿·Ö¹úÄÚÍâȨÍþÎÄÏ××ÊÁÏ£º

    1. iso 10993-10:2010 – biological evaluation of medical devices ¡ª part 10: tests for irritation and skin sensitization
    2. zhang, y., et al. (2021). "biocompatibility and wound healing performance of modified polyurethane dressings." biomaterials science, 9(4), 1345¨C1354.
    3. wang, l., et al. (2020). "development and characterization of a novel mdi-based hydrogel for chronic wound management." journal of biomedical materials research part a, 108(6), 1321¨C1332.
    4. european chemicals agency (echa). (2022). risk assessment report: methylene diphenyl diisocyanate (mdi).
    5. ¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾Ö. (2023). ¡¶Ò½Ó÷óÁÏÉúÎïѧÆÀ¼Û¼¼ÊõÉó²éÖ¸µ¼Ô­Ôò¡·
    6. liu, h., et al. (2019). "recent advances in polyurethane-based biomedical materials for wound care applications." advanced healthcare materials, 8(1), 1801234.
    7. us fda. (2020). guidance for industry and fda staff ¨C general wellness: policy for low risk devices.
    8. zhou, j., et al. (2022). "functionalized polyurethane films for smart wound dressing applications." acs applied materials & interfaces, 14(17), 19655¨C19667.

    Èç¹ûÄãϲ»¶ÕâÑùµÄÎÄÕ·ç¸ñ£¬»¶Ó­¼ÌÐø½»Á÷¡£ÎÒÃÇ¿ÉÒÔÒ»Æð̽ÌÖ¸ü¶à¹ØÓÚ²ÄÁÏ¿ÆÑ§¡¢Ò½ÁÆ´´ÐµĻ°Ìâ¡£±Ï¾¹£¬¿Æ¼¼µÄ½ø²½£¬´ÓÀ´¶¼²»ÊÇÀä±ù±ùµÄÊý¾Ý¶ÑÆö£¬¶øÊÇÓÐζȵÄÈËÎÄÓëÀíÐԵĽáºÏ¡£

    ÒµÎñÁªÏµ£ºÎâ¾­Àí 183-0190-3156 ΢ÐÅͬºÅ

    ÉÏһƪ£º
    ÏÂһƪ£º
    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿